To describe the patterns of use, clinical outcomes, and dose-volume histogram parameters of high-dose-rate interstitial brachytherapy (HDR-ISBT) in the management of Bartholin's gland cancer.
Bibliographical noteCopyright © 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging